IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 95 filers reported holding IGM BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,413,326 | -29.4% | 768,063 | -22.0% | 0.00% | -25.0% |
| Q2 2023 | $9,088,439 | +1150335.3% | 984,663 | +1613.6% | 0.00% | – |
| Q1 2023 | $790 | -86.1% | 57,460 | -82.8% | 0.00% | -100.0% |
| Q4 2022 | $5,684 | -99.9% | 334,185 | +14.8% | 0.00% | -25.0% |
| Q3 2022 | $6,622,000 | -37.7% | 291,215 | -50.6% | 0.00% | -42.9% |
| Q2 2022 | $10,627,000 | +79.6% | 589,401 | +166.3% | 0.01% | +133.3% |
| Q1 2022 | $5,916,000 | +23.2% | 221,312 | +35.1% | 0.00% | +50.0% |
| Q4 2021 | $4,803,000 | +60.5% | 163,754 | +259.8% | 0.00% | 0.0% |
| Q3 2021 | $2,993,000 | +30.1% | 45,514 | +51.7% | 0.00% | 0.0% |
| Q1 2021 | $2,301,000 | +551.8% | 30,000 | +650.0% | 0.00% | – |
| Q4 2020 | $353,000 | -78.5% | 4,000 | -82.0% | 0.00% | -100.0% |
| Q3 2020 | $1,641,000 | -51.6% | 22,231 | -52.1% | 0.00% | -60.0% |
| Q2 2020 | $3,390,000 | +559.5% | 46,445 | +406.9% | 0.01% | +400.0% |
| Q1 2020 | $514,000 | -88.6% | 9,162 | -96.4% | 0.00% | -85.7% |
| Q3 2019 | $4,504,000 | – | 253,790 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |